ArticleBMC cancer2018

Enhanced response rate to pegylated liposomal doxorubicin in high grade serous ovarian carcinomas harbouring BRCA1 and BRCA2 aberrations.

Robert L Hollis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.